Miron B - Search Results

1

Subclonal Therapy by Two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR-Mutated Lung Cancer.

Peled N, Roisman LC, Miron B, Pfeffer R, Lanman RB, Ilouze M, Dvir A, Soussan-Gutman L, Barlesi F, Tarcic G, Edelheit O, Gandara D, Elkabetz Y. Peled N, et al. Among authors: miron b. J Thorac Oncol. 2017 Jul;12(7):e81-e84. doi: 10.1016/j.jtho.2017.02.023. Epub 2017 Mar 7. J Thorac Oncol. 2017. PMID: 28286242 Free article. No abstract available.

2

Revisited analysis of a SHIVA01 trial cohort using functional mutational analyses successfully predicted treatment outcome.

Kamal M, Tarcic G, Dureau S, Edelheit O, Barbash Z, Lecerf C, Morel C, Miron B, Callens C, Servant N, Bieche I, Vidne M, Le Tourneau C. Kamal M, et al. Among authors: miron b. Mol Oncol. 2018 May;12(5):594-601. doi: 10.1002/1878-0261.12180. Epub 2018 Mar 30. Mol Oncol. 2018. PMID: 29464843 Free PMC article. Clinical Trial.

3

Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer.

Loree JM, Wang Y, Syed MA, Sorokin AV, Coker O, Xiu J, Weinberg BA, Vanderwalde AM, Tesfaye A, Raymond VM, Miron B, Tarcic G, Zelichov O, Broaddus RR, Ng PKS, Jeong KJ, Tsang YH, Mills GB, Overman MJ, Grothey A, Marshall JL, Kopetz S. Loree JM, et al. Among authors: miron b. Clin Cancer Res. 2021 Aug 15;27(16):4587-4598. doi: 10.1158/1078-0432.CCR-21-0180. Epub 2021 Jun 11. Clin Cancer Res. 2021. PMID: 34117033 Free PMC article.

4

A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus.

Ilson DH, Kelsen D, Shah M, Schwartz G, Levine DA, Boyd J, Capanu M, Miron B, Klimstra D. Ilson DH, et al. Among authors: miron b. Cancer. 2011 Apr 1;117(7):1409-14. doi: 10.1002/cncr.25602. Epub 2010 Nov 8. Cancer. 2011. PMID: 21425140 Free PMC article. Clinical Trial.

5

Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.

Miron B, Hoffman-Censits JH, Anari F, O'Neill J, Geynisman DM, Zibelman MR, Kutikov A, Viterbo R, Greenberg RE, Chen D, Lallas CD, Trabulsi EJ, Alpaugh RK, Dulaimi E, Golemis EA, Uzzo R, Ross EA, Plimack ER. Miron B, et al. Eur Urol Oncol. 2020 Aug;3(4):544-547. doi: 10.1016/j.euo.2020.02.003. Epub 2020 Mar 10. Eur Urol Oncol. 2020. PMID: 32165095 Free PMC article.

6

Paraneoplastic limbic encephalitis following treatment with single-agent pembrolizumab for advanced gastroesophageal adenocarcinoma.

Laderman L, Naveed O, LoPinto-Khoury C, Dotan E, Miron B. Laderman L, et al. Among authors: miron b. BMJ Case Rep. 2022 May 24;15(5):e247676. doi: 10.1136/bcr-2021-247676. BMJ Case Rep. 2022. PMID: 35609935

7

Placing Adjuvant Chemotherapy in the Evolving Paradigm of Perioperative Therapy for Bladder Cancer.

Miron B, Bukavina L, Plimack ER. Miron B, et al. Eur Urol. 2022 Jan;81(1):62-63. doi: 10.1016/j.eururo.2021.10.020. Epub 2021 Nov 5. Eur Urol. 2022. PMID: 34750037 No abstract available.

8

Bempegaldesleukin/Nivolumab and Challenges in First-line Treatment of Metastatic Urothelial Carcinoma.

Miron B, Geynisman DM. Miron B, et al. Eur Urol. 2022 Oct;82(4):374-376. doi: 10.1016/j.eururo.2022.05.023. Epub 2022 Jun 23. Eur Urol. 2022. PMID: 35752503 No abstract available.

9

Influence of first-line chemotherapy regimen on survival outcomes of patients with advanced urothelial carcinoma who received second-line immune checkpoint inhibitors.

Miron B, Handorf E, Zarrabi K, Zibelman MR, Anari F, Ghatalia P, Plimack ER, Geynisman DM. Miron B, et al. Urol Oncol. 2022 Oct;40(10):454.e9-454.e16. doi: 10.1016/j.urolonc.2022.05.028. Epub 2022 Jul 2. Urol Oncol. 2022. PMID: 35788287 Free PMC article.

10

Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma.

Zarrabi KK, Handorf E, Miron B, Zibelman MR, Anari F, Ghatalia P, Plimack ER, Geynisman DM. Zarrabi KK, et al. Among authors: miron b. Oncologist. 2023 Feb 8;28(2):157-164. doi: 10.1093/oncolo/oyac195. Oncologist. 2023. PMID: 36200791 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page